The use of monoclonal antibody to tumor necrosis factor in the treatment of refractory Crohn's disease in adolescents

被引：0
|
作者：
Serrano, MS [1 ]
Udall, JN [1 ]
Brown, RF [1 ]
Schmidt-Sommerfeld, E [1 ]
机构：
[1] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA
来源：
PEDIATRIC RESEARCH | 2000年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
989
引用
收藏
页码：168A / 168A
页数：1
相关论文
共 50 条
  • [31] Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behcet's disease
    Triolo, G
    Vadalà, M
    Accardo-Palumbo, A
    Ferrante, A
    Ciccia, F
    Giardina, E
    Citarrella, P
    Lodato, G
    Licata, G
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (06) : 560 - 561
  • [32] Antibodies to tumour necrosis factor α as treatment for Crohn's disease
    Bell, S
    Kamm, MA
    LANCET, 2000, 355 (9207): : 858 - 860
  • [33] Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: An expert consensus report
    Feagan, Brian G.
    Lemann, Marc
    Befrits, Ragnar
    Connell, William
    D'Haens, Geert
    Ghosh, Subrata
    Michetti, Pierre
    Ochsenkuehn, Thomas
    Panaccione, Remo
    Schreiber, Stefan
    Silverberg, Mark
    Sorrentino, Dario
    van der Woude, C. Janneke
    Vermeire, Severine
    Rutgeerts, Paul
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (01) : 152 - 160
  • [34] Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
    Suenaert, P
    Bulteel, V
    Lemmens, L
    Noman, M
    Geypens, B
    Van Assche, G
    Geboes, K
    Ceuppens, JL
    Rutgeerts, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (08): : 2000 - 2004
  • [35] Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease
    Bouguen, Guillaume
    Huguet, Audrey
    Amiot, Aurelien
    Viennot, Stephanie
    Cholet, Franck
    Nachury, Maria
    Flamant, Mathurin
    Reimund, Jean-Marie
    Desfourneaux, Veronique
    Boureille, Arnaud
    Siproudhis, Laurent
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (03) : 628 - 636
  • [36] Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab
    Tatò, F
    Rieger, J
    Hoffmann, U
    INTERNATIONAL ANGIOLOGY, 2005, 24 (03) : 304 - 307
  • [37] Tumor Necrosis Factor's Pathway in Crohn's Disease: Potential for Intervention
    Pagnini, Cristiano
    Cominelli, Fabio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [38] Medical options for treating Crohn's disease in adults:: Focus on antitumor necrosis factor-α chimeric monoclonal antibody
    Wall, GC
    Heyneman, C
    Pfanner, TP
    PHARMACOTHERAPY, 1999, 19 (10): : 1138 - 1152
  • [39] Infliximab: A novel chimeric monoclonal antibody for the treatment of Crohn's disease
    Mouser, JF
    Hyams, JS
    CLINICAL THERAPEUTICS, 1999, 21 (06) : 932 - 942
  • [40] Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn's disease
    Kupcova, V
    Turecky, L
    Detková, Z
    Príkazská, M
    Keleová, A
    PHYSIOLOGICAL RESEARCH, 2003, 52 (01) : 89 - 93
12345